CA1225646A - Pharmacologically active pyrazolo/4,3-c/pyridines - Google Patents

Pharmacologically active pyrazolo/4,3-c/pyridines

Info

Publication number
CA1225646A
CA1225646A CA000421751A CA421751A CA1225646A CA 1225646 A CA1225646 A CA 1225646A CA 000421751 A CA000421751 A CA 000421751A CA 421751 A CA421751 A CA 421751A CA 1225646 A CA1225646 A CA 1225646A
Authority
CA
Canada
Prior art keywords
formula
compound
alkyl
phenyl
pyrazolo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000421751A
Other languages
English (en)
French (fr)
Inventor
Giorgio Winters
Alberto Sala
Domenico Barone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Gruppo Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruppo Lepetit SpA filed Critical Gruppo Lepetit SpA
Application granted granted Critical
Publication of CA1225646A publication Critical patent/CA1225646A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA000421751A 1982-02-17 1983-02-16 Pharmacologically active pyrazolo/4,3-c/pyridines Expired CA1225646A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8204722 1982-02-17
GB8204722 1982-02-17

Publications (1)

Publication Number Publication Date
CA1225646A true CA1225646A (en) 1987-08-18

Family

ID=10528419

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000421751A Expired CA1225646A (en) 1982-02-17 1983-02-16 Pharmacologically active pyrazolo/4,3-c/pyridines

Country Status (16)

Country Link
US (1) US4500525A (OSRAM)
EP (1) EP0086422B1 (OSRAM)
JP (1) JPS58152885A (OSRAM)
KR (1) KR900006853B1 (OSRAM)
AT (1) ATE30027T1 (OSRAM)
AU (1) AU563591B2 (OSRAM)
CA (1) CA1225646A (OSRAM)
DE (1) DE3373904D1 (OSRAM)
DK (1) DK27383A (OSRAM)
ES (3) ES519832A0 (OSRAM)
GR (1) GR78080B (OSRAM)
IE (1) IE55156B1 (OSRAM)
IL (1) IL67785A0 (OSRAM)
NZ (1) NZ203302A (OSRAM)
PH (1) PH23645A (OSRAM)
ZA (1) ZA83628B (OSRAM)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137890A (en) * 1990-02-14 1992-08-11 Ortho Pharmaceutical Corporation 4-phenyl tetrahydropyrido(4,3-d)pyrimidines
US5264576A (en) * 1992-10-22 1993-11-23 Hoechst-Roussel Pharmaceuticals Incorporated Pyrazolo[4,3-c]pyridines which are intermediates
DE19834044A1 (de) * 1998-07-29 2000-02-03 Bayer Ag Neue substituierte Pyrazolderivate
US7332494B2 (en) 2000-08-14 2008-02-19 Janssen Pharmaceutica, N.V. Method for treating allergies using substituted pyrazoles
HK1052509B (en) * 2000-08-14 2007-09-07 Ortho-Mcneil Pharmaceutical, Inc. Substituted pyrazole
US20070117785A1 (en) * 2000-08-14 2007-05-24 Butler Christopher R Substituted pyrazoles and methods of treatment with substituted pyrazoles
US20070105841A1 (en) * 2000-08-14 2007-05-10 Breitenbucher J G Method for treating allergies using substituted pyrazoles
DE60118004T2 (de) 2000-08-14 2006-11-16 Ortho-Mcneil Pharmaceutical, Inc. Substituierte pyrazole
HK1052705B (en) * 2000-08-14 2006-09-29 Ortho-Mcneil Pharmaceutical, Inc. Substituted pyrazole
US20050101587A9 (en) * 2000-08-14 2005-05-12 Butler Christopher R. Method for treating allergies using substituted pyrazoles
AU8873001A (en) * 2000-09-06 2002-03-22 Ortho Mcneil Pharm Inc Method for treating allergies using substituted pyrazoles
AU2001288714A1 (en) 2000-09-06 2002-03-22 Ortho-Mcneil Pharmaceutical, Inc. A method for treating allergies
RU2286343C2 (ru) * 2001-08-10 2006-10-27 Орто-Макнейл Фармасьютикал, Инк. Замещенные пиразолы
KR20050013562A (ko) * 2002-05-30 2005-02-04 버텍스 파마슈티칼스 인코포레이티드 Ｊａｋ 및 ｃｄｋ2 프로테인 키나아제의 억제제
EP1526852A1 (en) * 2002-07-25 2005-05-04 Pharmacia Italia S.p.A. Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
EP2243781A1 (en) * 2003-05-30 2010-10-27 Vertex Pharmaceuticals, Inc. Pyrazolopyridine derivatives as inhibitors of JAK and CDK2 protein kinases
JP5069907B2 (ja) 2003-09-17 2012-11-07 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 縮合複素環式化合物
CA2539549A1 (en) 2003-09-23 2005-04-07 Vertex Pharmaceuticals Incorporated Pyrazolopyrrole derivatives as protein kinase inhibitors
KR100838692B1 (ko) 2007-07-11 2008-06-16 한국화학연구원 7-(3′,4′-디알콕시페닐)-4,5,6,7-테트라히드로피라졸로[1,5-ａ]피리미딘 화합물, 이의 제조방법 및 이를 포함하는천식 및 만성폐쇄성 폐질환을 포함한 염증관련 질환,관절염, 아토피 피부염, 암 및 뇌질환의 치료 및 예방을위한 약제학적 조성물
US9242981B2 (en) 2010-09-16 2016-01-26 Merck Sharp & Dohme Corp. Fused pyrazole derivatives as novel ERK inhibitors
KR20140075723A (ko) * 2011-09-12 2014-06-19 사노피 인다닐-치환된 4,5,6,7-테트라하이드로-1H-피라졸로[4,3,c]피리딘, 약물로서 그의 용도, 및 그를 포함한 약제학적 제제
BR112014005583A2 (pt) 2011-09-12 2017-03-21 Sanofi Sa 4,5,6,7-tetra-hidro-1h-pirazolo[4,3-c]piridinas substituídas com indanila, seu uso como medicamento, e preparações farmacêuticas que as contêm
ES2559450T3 (es) 2011-09-16 2016-02-12 Sanofi 4,5,6,7-Tetrahidro-1H-pirazolo[4,3-c]piridinas sustituidas, su uso como medicamento, y preparaciones farmacéuticas que las comprenden
BR112014006180A2 (pt) 2011-09-16 2017-04-11 Sanofi Sa 4, 5, 6, 7-tetraidro-1h-pirazol [4, 3-c] piridinas substituídas, seu uso como medicamento e preparações farmacêuticas que compreendem as mesmas
WO2016109663A2 (en) * 2014-12-30 2016-07-07 Novira Therapeutics, Inc. Derivatives and methods of treating hepatitis b infections
JP7014736B2 (ja) * 2016-05-24 2022-02-01 ジェネンテック， インコーポレイテッド がんの処置のためのピラゾロピリジン誘導体
ES2817426T3 (es) 2016-06-29 2021-04-07 Novira Therapeutics Inc Derivados de oxadiazepinona y su uso en el tratamiento de infecciones por hepatitis B
EP3478683B1 (en) 2016-06-29 2021-07-21 Novira Therapeutics Inc. Diazepinone derivatives and their use in the treatment of hepatitis b infections
MA48803A (fr) 2017-05-31 2020-04-08 Chemocentryx Inc Cycles 6-5 fusionnés utilisés en tant qu'inhibiteurs de c5a
CN111788185B (zh) * 2017-12-22 2024-12-13 凯莫森特里克斯股份有限公司 作为C5a抑制剂的二芳基取代的6,5稠合环化合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852279A (en) * 1973-03-12 1974-12-03 Squibb & Sons Inc 7-substituted -3,3a,4,5,6,7-hexahydro-3-substituted-2h- pyrazolo (4,3-c)pyridines

Also Published As

Publication number Publication date
JPH0412269B2 (OSRAM) 1992-03-04
KR840003636A (ko) 1984-09-15
IE830328L (en) 1983-08-17
DK27383D0 (da) 1983-01-25
AU1130583A (en) 1983-08-25
ES531981A0 (es) 1985-09-01
JPS58152885A (ja) 1983-09-10
EP0086422A2 (en) 1983-08-24
ATE30027T1 (de) 1987-10-15
ZA83628B (en) 1983-12-28
KR900006853B1 (ko) 1990-09-22
GR78080B (OSRAM) 1984-09-26
ES8507546A1 (es) 1985-09-01
ES8507547A1 (es) 1985-09-01
PH23645A (en) 1989-09-27
DE3373904D1 (en) 1987-11-05
ES531980A0 (es) 1985-09-01
US4500525A (en) 1985-02-19
ES8500273A1 (es) 1984-10-01
IL67785A0 (en) 1983-05-15
DK27383A (da) 1983-08-18
EP0086422A3 (en) 1984-03-28
ES519832A0 (es) 1984-10-01
EP0086422B1 (en) 1987-09-30
AU563591B2 (en) 1987-07-16
NZ203302A (en) 1986-08-08
IE55156B1 (en) 1990-06-20

Similar Documents

Publication Publication Date Title
CA1225646A (en) Pharmacologically active pyrazolo/4,3-c/pyridines
US5001130A (en) Psychotropic heterobicycloalkylpiperazine derivatives
EP0384349B1 (de) Substituierte Pyrrole
US5294619A (en) Arylpiperidine derivatives
CA2354606C (en) Azabicycloalkane derivatives and therapeutic uses thereof
US4210648A (en) II-Aminoacyl-5,11-dihydro-6H-pyrido(2,3-B) (1,4)benzodiazepin-6-ones and salts thereof
FI73999C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara piperazinyl-imidazo/4,5-b/- och -/4,5-c/ pyridiner samt mellanprodukt anvaendbar vid det.
JPS60188385A (ja) 置換ヘキサヒドロアリ−ルキノリジン類
US4677104A (en) Antipsychotic fused-ring pyridinylpiperazine derivatives
CA1177830A (en) Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
IE922270A1 (en) Pyrazole derivatives
EP0364091B1 (en) Antipsychotic 4-(4-(3-benzisothiazolyl)-1-piperazinyl)butyl bridged bicyclic imides
US4032640A (en) 4H-Benzo[4,5]cyclohepta[1,2-b]thiophenes
AU781663B2 (en) New pyrimidin-4-one compounds, a process for their preparation and pharmaceutical compositions containing them
CA1138864A (en) 4-phenyl-4,5,6,7-tetrahydro-pyrrolo[2,3-c] pyridines, process for the production thereof and pharmaceutical compositions
US4087433A (en) 1,5,10,11-Tetrahydrobenzo[4,5]-cyclohepta[1,2-b]pyrazolo[4,3-e]pyridines
CA2005547C (en) Derivatives of 1,7' (imidazo-(1,2-a)-pyridine)5'-(6'h)ones
US5116970A (en) Psychotropic heterobicycloalkylpiperazine derivatives: 2. fused pyridazinones
GB2174094A (en) Imidazo [1,5-a] pyridine derivatives
GB2111988A (en) Benzo-fused heterocyclic compounds
US5206365A (en) Psychotropic heterobicycloalkylpiperazine derivatives
US4572911A (en) Hexahydroindolinzine compounds, pharmaceutical compositions and methods and intermediates
GB2071093A (en) Benzothiopyrano(2,3-c)pyridines

Legal Events

Date Code Title Description
MKEX Expiry